Agilent Technologies and Eurofins Genomics Collaborate to Expand SureVector Cloning System
SANTA CLARA, Calif., and MILAN, March 10, 2016
Agilent Technologies Inc. (NYSE: A) and Eurofins Genomics today announced that Agilent plans to offer custom components and an assembled plasmid service for Agilent's SureVector next-generation cloning kits through a collaboration with Eurofins. Agilent will also offer a set of catalog components for its leading-edge SureVector cloning kits, enabling the creation of over 1 million different cloning vectors.
Agilent has been a leading provider of molecular biology tools since it acquired Stratagene in 2007. It is one of the few companies whose products address the entire workflow for molecular and synthetic biology, and SureVector continues to expand this portfolio.
Eurofins Genomics, a division of the Eurofins Scientific Group, is a leading provider of DNA sequencing services, genotyping services, DNA synthesis products and bioinformatics services.
The world's first modular vector kit, SureVector enables biologists to construct customized vectors-small DNA molecules within cells that can replicate independently-from standard components.
"SureVector is part of Agilent's continued commitment to providing revolutionary tools for molecular biology," said Alessandro Borsatti, head of genomics marketing for Agilent.
Components of the SureVector system are functional DNA modules that can be rapidly combined to assemble into vectors. As a result, what used to take biologists two hours of hands-on time can be done in less than 30 minutes. The newly released kits contain standard parts for mammalian, E. coli and yeast cells, with Eurofins offering the ability to create custom components for any organism.
"SureVector is an ideal addition to Eurofins Genomics' gene synthesis and GeneStrands services," said Uwe Koehler, head of Gene Synthesis and Molecular Biology for Eurofins Genomics. "In this exclusive collaboration, Eurofins Genomics can now offer tailor-made SureVector plasmids, and any component of the SureVector kit can be replaced with customer-specific elements."
"The Eurofins collaboration is an exciting step forward for SureVector," said Agilent's Borsatti. "It allows us to offer customers individual vectors or the ability to customize any fragment in the SureVector system."
About Eurofins Genomics
Eurofins Genomics, a member of the Eurofins Group with facilities in Europe, the United States and Asia, is an internationally leading provider of DNA sequencing services, genotyping services, DNA synthesis products and bioinformatics services for pharma, diagnostics, food, agriculture, biotechnological and research markets. The company's strength is its customer support and high quality services in industrial scale for the life science industries and academic research institutions around the world. For further information, visit eurofinsgenomics.com.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics and applied chemical markets, is the premier laboratory partner for a better world. Agilent works with customers in more than 100 countries, providing instruments, software, services and consumables for the entire laboratory workflow. The company generated revenues of $4.04 billion in fiscal 2015 and employs about 12,000 people worldwide. Information about Agilent is available at www.agilent.com.
# # #
Victoria Wadsworth-Hansen, Agilent
+1 408 553 2005
Carola Grimminger, Eurofins Genomics
+49 8092 8289-0